151 related articles for article (PubMed ID: 30095597)
1. SURGICAL MANAGEMENT OF FULL-THICKNESS MACULAR HOLE SUPERIMPOSED ON EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Shif OA; Katz MSJ
Retin Cases Brief Rep; 2021 May; 15(3):211-213. PubMed ID: 30095597
[TBL] [Abstract][Full Text] [Related]
2. INCIDENCE AND LONG-TERM VISUAL ACUITY OUTCOMES OF RETINAL PIGMENT EPITHELIUM TEARS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Vazquez-Alfageme C; Nicholson L; Hamilton RD; Patel PJ
Retina; 2019 Apr; 39(4):664-669. PubMed ID: 29324593
[TBL] [Abstract][Full Text] [Related]
3. REOPENING OF MACULAR HOLE AFTER INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Chan EW; Sun V; Chen JC
Retin Cases Brief Rep; 2020; 14(3):255-259. PubMed ID: 29252912
[TBL] [Abstract][Full Text] [Related]
4. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
[TBL] [Abstract][Full Text] [Related]
5. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
[TBL] [Abstract][Full Text] [Related]
6. Ranibizumab for the treatment of exudative age-related macular degeneration associated with retinal pigment epithelial tear.
Rouvas AA; Ladas ID; Georgalas I; Vergados I; Papakonstantinou D; Kotsolis AI
Retina; 2011 Jun; 31(6):1083-8. PubMed ID: 21427630
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
Kitagawa Y; Shimada H; Mori R; Tanaka K; Yuzawa M
Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
[TBL] [Abstract][Full Text] [Related]
8. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by pars plana vitrectomy.
Okamoto T; Shinoda H; Kurihara T; Nagai N; Tsubota K; Ozawa Y
BMC Ophthalmol; 2014 Sep; 14():114. PubMed ID: 25270019
[TBL] [Abstract][Full Text] [Related]
10. RELATIVE QUIESCENCE OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION AFTER RESOLUTION OF POSTINJECTION ENDOPHTHALMITIS.
Arnett JJ; Brodowska K; Gallagher DS; Eller AW; Friberg TR; Anetakis AJ; Martel JN
Retina; 2020 Sep; 40(9):1719-1723. PubMed ID: 31800459
[TBL] [Abstract][Full Text] [Related]
11. Macular hole formation following intravitreal injection of ranibizumab for branch retinal vein occlusion: a case report.
Muramatsu D; Mitsuhashi R; Iwasaki T; Goto H; Miura M
BMC Res Notes; 2015 Aug; 8():358. PubMed ID: 26285577
[TBL] [Abstract][Full Text] [Related]
12. RANIBIZUMAB IN PIGMENT EPITHELIAL TEARS SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Prospective Study.
Larsen PP; Oishi A; Bedar MS; Heymer PKR; Clemens CR; König S; Gutfleisch M; Pauleikhoff D; Eter N; Wolf A; Holz FG; Krohne TU
Retina; 2019 Dec; 39(12):2369-2377. PubMed ID: 30198967
[TBL] [Abstract][Full Text] [Related]
13. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS.
Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ
Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524
[TBL] [Abstract][Full Text] [Related]
14. Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.
Kang HM; Lee SJ; Kim CG; Chung EJ; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1681-92. PubMed ID: 26743753
[TBL] [Abstract][Full Text] [Related]
15. FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity.
Monés J; Biarnés M; Trindade F; Casaroli-Marano R
Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1737-44. PubMed ID: 22527314
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.
Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH
Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749
[TBL] [Abstract][Full Text] [Related]
17. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
18. Full-thickness macular hole formation associated with central serous chorioretinopathy.
Amde W; Tewari A
Eur J Ophthalmol; 2012; 22(6):1039-41. PubMed ID: 22729443
[TBL] [Abstract][Full Text] [Related]
19. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
Gomi F; Sawa M; Tsujikawa M; Nishida K
Retina; 2012 Oct; 32(9):1804-10. PubMed ID: 22718152
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
Shin JY; Choi M; Chung B; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
